Analyst firms · Oppenheimer · REGN

Oppenheimer REGN price target and rating history

Regeneron Pharmaceuticals Inc. (REGN) · Health Care

Oppenheimer rates Regeneron Pharmaceuticals Inc. (REGN) Perform with a $1,050 price target, as of its latest action on Aug 21, 2023. It has published 3 rating actions on REGN since August 2021, including 0 upgrades and 0 downgrades. Across 9 firms with a REGN price target in the last 12 months, the median target is $798.

Current rating
Perform
Price target
$1,050
Median target, all firms
$798
Actions on REGN
3

Oppenheimer price target on REGN

$1,050$913$77520222023202420252026
Oppenheimer price target on REGN, each point a stated target, August 2021 to August 2023.

Every Oppenheimer rating on REGN

How other firms rate REGN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Argus ResearchBuy$850Oct 1, 2026
CitigroupNeutral$700May 18, 2026
Leerink PartnersMarket Perform$641May 18, 2026
Piper SandlerOverweight$875Mar 31, 2026
BarclaysOverweight$923Mar 6, 2026
BofA SecuritiesBuy$860Jan 7, 2026
Morgan StanleyEqual-Weight$767Dec 3, 2025
Truist SecuritiesBuy$798Nov 24, 2025
HSBCBuy$255Nov 24, 2025

Questions about Oppenheimer and REGN

What is Oppenheimer's price target for REGN?
Oppenheimer's latest stated price target for Regeneron Pharmaceuticals Inc. (REGN) is $1,050, from its action on Aug 21, 2023.
What is Oppenheimer's rating on REGN?
Oppenheimer rates REGN Perform, a neutral rating, as of Aug 21, 2023.
When did Oppenheimer last change its view on REGN?
On Aug 21, 2023, Oppenheimer raises its price target to $1,050 from $950, keeps Perform.
How does Oppenheimer's REGN target compare with other analysts?
Across 9 firms with a REGN price target in the last 12 months, the median target is $798.

More REGN rating histories

All Oppenheimer ratingsREGN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.